MiR-125b functions as a key mediator for snail-induced stem cell propagation and chemoresistance

Journal of Biological Chemistry

Volumn 288, Issue 6, 2013, Pages 4334-4345

  Liu, Zixing ^a   Liu, Hao ^a,b   Desai, Shruti ^a   Schmitt, David C ^a   Zhou, Ming ^c   Khong, Hung T ^d   Klos, Kristine S ^e   McClellan, Steven ^a   Fodstad, Oystein ^f   Tan, Ming ^a  

^a UNIVERSITY OF SOUTH ALABAMA   (United States)

^b SICHUAN UNIVERSITY   (China)

^c CENTRAL SOUTH UNIVERSITY   (China)

^d UNIVERSITY OF UTAH   (United States)

^e UNIVERSITY OF WISCONSIN MADISON   (United States)

^f UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALS; CELL CULTURE; CELL PROLIFERATION; CELLS; CHEMOTHERAPY; CYTOLOGY; DISEASES; MOLLUSCS; STEM CELLS;

B FUNCTIONS; CANCER CELLS; CANCER STEM CELLS; CHEMORESISTANCE; OVER-EXPRESSION; UP-REGULATION; WNT SIGNALING;

CELL SIGNALING;

BETA CATENIN; GEMCITABINE; MICRORNA 125B; PACLITAXEL; PROTEIN BAK; PROTEIN BAK1; PROTEIN TCF4; T CELL FACTOR PROTEIN; TRANSCRIPTION FACTOR SNAIL; UNCLASSIFIED DRUG; WNT PROTEIN;

ARTICLE; BINDING AFFINITY; BINDING SITE; BREAST CANCER; CANCER CELL; CANCER RESISTANCE; CANCER STEM CELL; CELL POPULATION; CHEMORESISTANCE; CONCENTRATION RESPONSE; CONTROLLED STUDY; GENE FUNCTION; GENE OVEREXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEPLETION; PROTEIN EXPRESSION; TRANSCRIPTION INITIATION; UPREGULATION;

EID: 84873638537     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M112.419168     Document Type: Article

References (46)

1. Giaccone, G., and Pinedo, H. M. (1996) Drug Resistance. Oncologist 1, 82-87
2. Arbuck, S. G., Dorr, A., and Friedman, M. A. (1994) Paclitaxel (Taxol) in breast cancer. Hematol. Oncol. Clin. North Am. 8, 121-140
3. Hortobagyi, G. N., Holmes, F. A., Theriault, R. L., and Buzdar, A. U. (1994) Use of Taxol (paclitaxel) in breast cancer. Oncology 51, 29-32
4. Meden, H., Rath, W., and Kuhn, W. (1994) Taxol-a new cytostatic drug for therapy of ovarian and breast cancer. Geburtshilfe Frauenheilkd 54, 187-193
5. Sledge, G. W., Jr., Robert, N., Sparano, J. A., Cobeligh, M., Goldstein, L. J., Neuberg, D., Rowinsky, E., Baughman, C., and McCaskill-Stevens, W. (1994) Paclitaxel (Taxol)/doxorubicin combinations in advanced breast cancer: the Eastern Cooperative Oncology Group experience. Semin. Oncol. 21, 15-18
6. Bishop, J.F., Dewar, J., Toner, G. C., Tattersall, M.H., Olver, I.N., Ackland, S., Kennedy, I., Goldstein, D., Gurney, H., Walpole, E., Levi, J., and Ste-phenson, J. (1997) Paclitaxel as first-line treatment for metastatic breast cancer. The Taxol Investigational Trials Group, Australia and New Zealand. Oncology 11, 19-23
7. Gupta, P. B., Onder, T. T., Jiang, G., Tao, K., Kuperwasser, C., Weinberg, R. A., and Lander, E. S. (2009) Identification of selective inhibitors of cancer stem cells by high-throughput screening. Cell 138, 645-659
8. Donnenberg, V. S., and Donnenberg, A.D.(2005) Multiple drug resistance in cancer revisited: the cancer stem cell hypothesis. J. Clin. Pharmacol. 45, 872-877
9. Parekh, H., Wiesen, K., and Simpkins, H. (1997) Acquisition of taxol resistance via P-glycoprotein-and non-P-glycoprotein-mediated mechanisms in human ovarian carcinoma cells. Biochem. Pharmacol. 53, 461-470
10. Orr, G. A., Verdier-Pinard, P., McDaid, H., and Horwitz, S. B. (2003) Mechanisms of Taxol resistance related to microtubules. Oncogene 22, 7280-7295
11. Blanco, M. J., Moreno-Bueno, G., Sarrio, D., Locascio, A., Cano, A., Pala-cios, J., and Nieto, M. A. (2002) Correlation of Snail expression with his-tological grade and lymph node status in breast carcinomas. Oncogene 21, 3241-3246
12. Côme, C., Magnino, F., Bibeau, F., De Santa Barbara, P., Becker, K. F., Theillet, C., and Savagner, P. (2006) Snail and slug play distinct roles during breast carcinoma progression. Clin. Cancer Res. 12, 5395-5402
13. Mani, S. A., Guo, W., Liao, M. J., Eaton, E. N., Ayyanan, A., Zhou, A. Y., Brooks, M., Reinhard, F., Zhang, C. C., Shipitsin, M., Campbell, L. L., Polyak, K., Brisken, C., Yang, J., and Weinberg, R. A. (2008) The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133, 704-715
14. Iorio, M. V., Ferracin, M., Liu, C. G., Veronese, A., Spizzo, R., Sabbioni, S., Magri, E., Pedriali, M., Fabbri, M., Campiglio, M., Ménard, S., Palazzo, J. P., Rosenberg, A., Musiani, P., Volinia, S., Nenci, I., Calin, G. A., Querzoli, P., Negrini, M., and Croce, C. M. (2005) MicroRNA gene expression deregulation in human breast cancer. Cancer Res. 65, 7065-7070
15. Ozen, M., Creighton, C. J., Ozdemir, M., and Ittmann, M. (2008) Widespread deregulation of microRNA expression in human prostate cancer. Oncogene 27, 1788-1793
16. Zhang, L., Volinia, S., Bonome, T., Calin, G. A., Greshock, J., Yang, N., Liu, C. G., Giannakakis, A., Alexiou, P., Hasegawa, K., Johnstone, C. N., Me-graw, M. S., Adams, S., Lassus, H., Huang, J., Kaur, S., Liang, S., Sethupa-thy, P., Leminen, A., Simossis, V. A., Sandaltzopoulos, R., Naomoto, Y., Katsaros, D., Gimotty, P. A., DeMichele, A., Huang, Q., Bützow, R., Rustgi, A. K., Weber, B. L., Birrer, M. J., Hatzigeorgiou, A. G., Croce, C. M., and Coukos, G. (2008) Genomic and epigenetic alterations deregulate mi-croRNA expression in human epithelial ovarian cancer. Proc. Natl. Acad. Sci. U.S.A. 105, 7004-7009
17. Yu, F., Yao, H., Zhu, P., Zhang, X., Pan, Q., Gong, C., Huang, Y., Hu, X., Su, F., Lieberman, J., and Song, E. (2007) let-7 regulates self renewal and tu-morigenicity of breast cancer cells. Cell 131, 1109-1123
18. Shimono, Y., Zabala, M., Cho, R. W., Lobo, N., Dalerba, P., Qian, D., Diehn, M., Liu, H., Panula, S. P., Chiao, E., Dirbas, F. M., Somlo, G., Pera, R. A., Lao, K., and Clarke, M. F. (2009) Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells. Cell 138, 592-603
19. Zhou, M., Liu, Z., Zhao, Y., Ding, Y., Liu, H., Xi, Y., Xiong, W., Li, G., Lu, J., Fodstad, O., Riker, A. I., and Tan, M. (2010) MicroRNA-125b confers the resistance of breast cancer cells to paclitaxel through suppression of pro-apoptotic Bcl-2 antagonist killer 1 (Bak1) expression. J. Biol. Chem. 285, 21496-21507
20. Wang, H., Tan, G., Dong, L., Cheng, L., Li, K., Wang, Z., and Luo, H. (2012) Circulating MiR-125b as a marker predicting chemoresistance in breast cancer. PLoS One 7, e34210
21. Ebert, M. S., Neilson, J. R., and Sharp, P. A. (2007) MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells. Nat Methods 4, 721-726
22. Edbauer, D., Neilson, J. R., Foster, K. A., Wang, C. F., Seeburg, D. P., Batterton, M. N, Tada, T., Dolan, B. M., Sharp, P. A., and Sheng, M. (2010) Regulation of synaptic structure and function by FMRP-associated mi-croRNAs miR-125b and miR-132. Neuron 65, 373-384
23. Zhou, R., Hu, G., Liu, J., Gong, A. Y., Drescher, K. M., and Chen, X. M. (2009) NF-kappaB p65-dependent transactivation of miRNA genes following Cryptosporidium parvum infection stimulates epithelial cell immune responses. PLoS Pathog. 5, e1000681
24. Yin, T., Wang, C, Liu, T., Zhao, G., Zha, Y., and Yang, M. (2007) Expression of snail in pancreatic cancer promotes metastasis and chemoresistance. J. Surg. Res. 141, 196-203
25. Kurrey, N. K., Jalgaonkar, S. P., Joglekar, A. V., Ghanate, A. D., Chaskar, P. D., Doiphode, R. Y., and Bapat, S. A. (2009) Snail and slug mediate radioresistance and chemoresistance by antagonizing p53-mediated apo-ptosis and acquiring a stem-like phenotype in ovarian cancer cells. Stem Cells 27, 2059-2068
26. Wang, Z., Li, Y., Kong, D., Banerjee, S., Ahmad, A., Azmi, A. S., Ali, S., Abbruzzese, J. L., Gallick, G. E., and Sarkar, F. H. (2009) Acquisition of epithelial-mesenchymal transition phenotype of gemcitabine-resistant pancreatic cancer cells is linked with activation of the notch signaling pathway. Cancer Res. 69, 2400-2407
27. Chen, W. J., Wang, H., Tang, Y., Liu, C. L., Li, H. L., and Li, W. T. (2010) Multidrug resistance in breast cancer cells during epithelial-mesenchymal transition is modulated by breast cancer resistant protein. Chin. J. Cancer 29, 151-157
28. Stemmer, V., de Craene, B., Berx, G., and Behrens, J. (2008) Snail promotes Wnt target gene expression and interacts with β-catenin. Oncogene 27, 5075-5080
29. Medici, D., Hay, E. D., and Olsen, B. R. (2008) Snail and Slug promote epithelial-mesenchymal transition through β-catenin-T-cell factor-4-dependent expression of transforming growth factor-β3. Mol. Biol. Cell 19, 4875-4887
30. Shi, X. B., Xue, L., Yang, J., Ma, A. H., Zhao, J., Xu, M., Tepper, C. G., Evans, C. P., Kung, H. J., and deVere White, R. W. (2007) An androgen-regulated miRNA suppresses Bak1 expression and induces androgen-independent growth of prostate cancer cells. Proc. Natl. Acad. Sci. U.S.A. 104, 19983-19988
31. Rossi, R. L., Rossetti, G., Wenandy, L., Curti, S., Ripamonti, A., Bonnal, R. J., Birolo, R. S., Moro, M., Crosti, M. C, Gruarin, P., Maglie, S., Marabita, F., Mascheroni, D., Parente, V., Comelli, M., Trabucchi, E., De Francesco, R., Geginat, J., Abrignani, S., and Pagani, M. (2011) Distinct microRNA signatures in human lymphocyte subsets and enforcement of the naive state in CD4+ T cells by the microRNA miR-125b. Nat. Immunol. 12, 796-803
32. Guo, S., Lu, J., Schlanger, R., Zhang, H., Wang, J. Y., Fox, M. C, Purton, L. E., Fleming, H. H., Cobb, B., Merkenschlager, M., Golub, T. R., and Scadden, D. T. (2010) MicroRNA miR-125a controls hematopoietic stem cell number. Proc. Natl. Acad. Sci. U.S.A. 107, 14229-14234
33. Creighton, C.J., Li, X., Landis, M., Dixon, J. M., Neumeister, V. M., Sjolund, A., Rimm, D. L., Wong, H., Rodriguez, A., Herschkowitz, J. I., Fan, C., Zhang, X., He, X., Pavlick, A., Gutierrez, M. C., Renshaw, L., Larionov, A. A., Faratian, D., Hilsenbeck, S. G., Perou, C. M., Lewis, M. T., Rosen, J. M., and Chang, J. C. (2009) Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features. Proc. Natl. Acad. Sci. U.S.A. 106, 13820-13825
34. Dean, M., Fojo, T., and Bates, S. (2005) Tumour stem cells and drug resistance. Nat. Rev. Cancer 5, 275-284
35. Moody, S. E., Perez, D., Pan, T. C., Sarkisian, C. J., Portocarrero, C. P., Sterner, C. J., Notorfrancesco, K. L., Cardiff, R. D., and Chodosh, L. A. (2005) The transcriptional repressor Snail promotes mammary tumor recurrence. Cancer Cell 8, 197-209
36. O'Connell, R. M., Chaudhuri, A. A., Rao, D. S., Gibson, W. S., Balazs, A. B., and Baltimore, D. (2010) MicroRNAs enriched in hematopoietic stem cells differentially regulate long-term hematopoietic output. Proc. Natl. Acad. Sci. U.S.A. 107, 14235-14240
37. Mizuno, Y., Yagi, K., Tokuzawa, Y., Kanesaki-Yatsuka, Y., Suda, T., Kata-giri, T., Fukuda, T., Maruyama, M., Okuda, A., Amemiya, T., Kondoh, Y., Tashiro, H., and Okazaki, Y. (2008) miR-125b inhibits osteoblastic differentiation by down-regulation of cell proliferation. Biochem. Biophys. Res. Commun. 368, 267-272
38. Gururajan, M., Haga, C. L., Das, S., Leu, C. M., Hodson, D., Josson, S., Turner, M., and Cooper, M. D. (2010) MicroRNA 125b inhibition of B cell differentiation in germinal centers. Int. Immunol. 22, 583-592
39. Bousquet, M., Quelen, C., Rosati, R., Mansat-De Mas, V., La Starza, R., Bastard, C., Lippert, E., Talmant, P., Lafage-Pochitaloff, M., Leroux, D., Gervais, C., Viguié, F., Lai, J. L., Terre, C., Beverlo, B., Sambani, C., Hage-meijer, A., Marynen, P., Delsol, G., Dastugue, N., Mecucci, C., and Brous-set, P. (2008) Myeloid cell differentiation arrest by miR-125b-1 in myelo-dysplastic syndrome and acute myeloid leukemia with the t(2;11)(p21; q23) translocation. J. Exp. Med. 205, 2499-2506
40. Bousquet, M., Harris, M. H., Zhou, B., and Lodish, H.F. (2010) MicroRNA miR-125b causes leukemia. Proc. Natl. Acad. Sci. U.S.A. 107, 21558-21563
41. Shi, X. B., Xue, L., Ma, A. H., Tepper, C. G., Kung, H. J., and White, R. W. (2011) miR-125b promotes growth of prostate cancer xenograft tumor through targeting pro-apoptotic genes. Prostate 71, 538-549
42. Bockmeyer, C. L., Christgen, M., Muller, M., Fischer, S., Ahrens, P., Langer, F., Kreipe, H., and Lehmann, U. (2011) MicroRNA profiles of healthy basal and luminal mammary epithelial cells are distinct and reflected in different breast cancer subtypes. Breast Cancer Res. Treat. 130, 735-745
43. Li, X., Zhang, J., Gao, L., McClellan, S., Finan, M. A., Butler, T. W., Owen, L. B., Piazza, G. A., and Xi, Y. (2011) MiR-181 mediates cell differentiation by interrupting the Lin28 and let-7 feedback circuit. Cell Death Differ. 19, 378-386
44. Li, Z., Yang, C. S., Nakashima, K., and Rana, T. M. (2011) Small RNA-mediated regulation of iPS cell generation. EMBO J. 30, 823-834
45. Chang, C. J., Chao, C. H., Xia, W., Yang, J. Y., Xiong, Y., Li, C. W., Yu, W. H., Rehman, S.K., Hsu, J. L., Lee, H.H., Liu, M., Chen, C.T., Yu, D., and Hung, M. C. (2011) p53 regulates epithelial-mesenchymal transition and stem cell properties through modulating miRNAs. Nat. Cell Biol. 13, 317-323
46. Le, M. T., Teh, C., Shyh-Chang, N., Xie, H., Zhou, B., Korzh, V., Lodish, H. F., and Lim, B. (2009) MicroRNA-125b is a novel negative regulator of p53. Genes Dev. 23, 862-876